Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3

This publication has 15 references indexed in Scilit:

• Induction of tumor‐cell lysis by bi‐specific antibody recognizing ganglioside GD2 and T‐cell antigen CD3
  International Journal of Cancer, 1993
• Bispecific-monoclonal-antibody-directed lysis of ovarian carcinoma cells by activated human T lymphocytes
  Cancer Immunology, Immunotherapy, 1991
• Bispecific antibodies and targeted cellular cytotoxicity
  Immunology Today, 1991
• T cell targeting in cancer therapy
  Cancer Immunology, Immunotherapy, 1991
• Preliminary trial of specific targeting therapy against malignant glioma
  The Lancet, 1990
• Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and cd3 antigen
  International Journal of Cancer, 1989
• Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.
  The Journal of Experimental Medicine, 1986
• Preparation of Bispecific Antibodies by Chemical Recombination of Monoclonal Immunoglobulin G ₁ Fragments
  Science, 1985
• MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF
  Biochemical and Biophysical Research Communications, 1985
• Hybrid antibodies can target sites for attack by T cells
  Nature, 1985